No Data
Investing in Blueprint Medicines (NASDAQ:BPMC) a Year Ago Would Have Delivered You a 78% Gain
The simplest way to invest in stocks is to buy exchange traded funds. But you can significantly boost your returns by picking above-average stocks. To wit, the Blueprint Medicines Corporation (NASDA
Unusual Options Activity: APA, LNG and Others Attract Market Bets, APA V/OI Ratio Reaches 420.0
EST Jun 11th Morning Delivery - In the last two hours of trading, 9 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.O
Wells Fargo Maintains Blueprint Medicines(BPMC.US) With Buy Rating
Wells Fargo analyst Derek Archila maintains $Blueprint Medicines(BPMC.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 40.2% and a total average return of 5.6% over
Insider Sale: Chief Scientific Officer Percy Carter Sells Shares of Blueprint Medicines Corp (BPMC)
Blueprint Medicines(BPMC.US) Officer Sells US$420.52K in Common Stock
$Blueprint Medicines(BPMC.US)$ Officer Carter Percy H. sold 4,000 shares of common stock on Jun 5, 2024 at an average price of $105.13 for a total value of $420.52K.Source: Announcement What is statem
Blueprint Medicines Insider Sold Shares Worth $420,520, According to a Recent SEC Filing
Percy H. Carter, Chief Scientific Officer, on June 05, 2024, sold 4,000 shares in Blueprint Medicines (BPMC) for $420,520. Following the Form 4 filing with the SEC, Carter has control over a total of